Is Eli Lilly Endangering Type 2 Diabetics?
In this video, we delve into the business decision made by pharmaceutical giant Eli Lilly. With the release of #zepbound, a weight loss drug, during a global shortage of the medication #mounjaro for type 2 diabetics, questions arise about the prioritization of profit over people's health.
Join us as we discuss the implications of Eli Lilly's actions and explore whether the company's decision may have jeopardized the well-being of those using Mounjaro. We'll examine the considerations surrounding this decision and its potential impact on individuals managing type 2 diabetes worldwide.
With keywords like "profit over people," "Mounjaro," and "Zepbound," this video discusses the critical importance of putting patient welfare first. Watch now to gain insight into this pressing issue and join the conversation on healthcare responsibilities and corporate responsibility.
👉 To learn more about Tirzepatide, Mounjaro and Zepbound visit https://tirzepatide.lilly.com/
0:00 // Intro
0:18 // Tirzepatide
0:27 // Mounjaro
1:19 // Speak With Your Doctor
1:37 // Zepbound
2:07 // What Is The Difference
2:15 // Global Supply Shortage
2:52 // A Math Problem
7:30 // 150 Years of Lilly
8:03 // A Business Decision
8:24 // Profit Over People
👉Find GraymanPOTA On Social Media: https://GraymanPOTA.com
👉Snail Mail: GraymanPOTA, PO Box 1252, Martinsville, IN 46151
Disclaimer:
All opinions presented in this video are my personal opinions and should not be construed as an endorsement of any manufacturer, distributor, product, or service. No prior business relationship exists between the manufacturer or distributor of any product or service featured in this video and myself unless specifically stated in the video. All information in this video is provided as-is and I make no representations as to the accuracy of the information. Before purchasing any product or service featured in this video, please do your own research regarding the manufacturer or distributor of any product or service. Not all products or services featured in this video may be appropriate for all localities, please check your local laws and regulations regarding the use of any product or service featured in this video.
-
1:20:19
itsgregballew
1 year agoWhy Live With Diabetes
48 -
45:39
Tuckergoodrich
3 months agoEp. 18: What Causes Insulin Resistance?—with Matt Quinn and Dr. Brian Kerley
75 -
2:20
coloradomedicalsolutions
11 months agoEli Lilly’s new medication for obesity, Retatrutide!
54 -
34:46
the UK carnivore
2 months ago $0.49 earnedShocking news for Type 1 Diabetics: Insulin discontinued
6051 -
29:23
Alan Roberts
1 year agoType 2 Diabetes Could Destroy The Country | I Told You So
404 -
9:02
Biological Medicine
1 year agoThe American Academy of Pediatrics greenlighting dangerous drugs for obesity
216 -
4:46
Dr. Becky Fitness
2 months agoInsulin Resistant? Eat This FIRST!
3941 -
0:35
WRTV
7 years agoEli Lilly announces insulin discounts
-
25:01
Waking the World up
1 year agoAlexandra Latypova - COVID-19 countermeasures - Evidence of an Intent to Harm
581 -
14:26
majorityreport
1 year agoHow Eli Lilly Was Forced To Lower Insulin Prices
274